Sue Xu
Managing Partner at Amino Capital
San Francisco Bay Area
Invests in
Stages:
Sectors:
Locations:
Min Investment:
$0.00Max Investment:
$10,000,000.00Target Investment:
$500,000.00
Skills
Education
Lists including Sue
Investments
Fixposition
Total Funding: $14M
Peakflo
Total Funding: $4M
Benepass
Total Funding: $35M
Firstbase
Total Funding: $65M
d-Matrix
Total Funding: $150M
GetAccept
Total Funding: $29M
Turing
Total Funding: $9M
Meituan Bike
Total Funding: $820M
DFINITY
Total Funding: $230M
Oasis Labs
Total Funding: $45M
Replit
Total Funding: $200M
NuCypher
Total Funding: $4.8M
Beyond One, Inc.
Total Funding: $240K
Rippling
Total Funding: $1.4B
Grail
Total Funding: $1.3B
Menusifu
Total Funding:
InnoGrit Corporation
Total Funding:
AiFi
Total Funding: $15M
Unbabel
Total Funding: $92M
Guesty
Total Funding: $430M
Weee!
Total Funding: $780M
Instawork
Total Funding: $170M
Avail Medsystems
Total Funding:
Chime
Total Funding: $1.5B
Webflow
Total Funding: $340M
HealthCrowd
Total Funding: $500K
Work Experience
2012
Managing Partner
2012
Dr. Sue Xu is a Managing Partner at Amino Capital and joined the firm in 2012, with investment theme of data moat, network effect and domain agnostic. She has successful investments from inception to unicorn in Generative AI, Consumer, SaaS and Frontier tech. She was founding CEO of CandyHouse and CyteSi, both Stanford lab spin-offs. Since 2012, she has involved with more than 300 investments mostly in seed and Series A, with around 20 unicorns and over 35 companies with valuation higher than $100M, including Chime, Rippling, Grail(acquired by Illumina), Webflow, Weee, DFINITY, Replit, Oasis Labs, OmiseGo, Turing, Wyze, GetAccept, Guesty, Instawork, Wetravel, StarRocks, Karbon Card, Unbabel, and WriteSonic. Dr. Sue Xu began her early stage entrepreneurship when she was the founding scientist of GlycoMira (also involved in undergrad and PhD laboratory spin-offs). She has three patents and over 20 journal publications, and previously was a medical school researcher at Stanford University.
2020
Investor
2020
Series A Investor
2018
Investor
2018
Seed Round Investor
2017
Investor
2017
Seed Round Investor
2017
Investor
2017
Seires B Investor
2015
Investor
2015
Seed Round Investor
2015
Investor
2015
Seed Round Investor
2016
Investor
2016
Seed Round Investor
2013
Investor
2013
Seed Round Investor
2013
Investor
2013
Seed Round Investor